 |
PDBsum entry 4fob
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transferase/inhibitor
|
PDB id
|
|
|
|
4fob
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
|
|
Key reference
|
|
|
Title
|
|
The discovery and optimization of a novel class of potent, Selective, And orally bioavailable anaplastic lymphoma kinase (alk) inhibitors with potential utility for the treatment of cancer.
|
|
|
Authors
|
|
R.T.Lewis,
C.M.Bode,
D.M.Choquette,
M.Potashman,
K.Romero,
J.C.Stellwagen,
Y.Teffera,
E.Moore,
D.A.Whittington,
H.Chen,
L.F.Epstein,
R.Emkey,
P.S.Andrews,
V.L.Yu,
D.C.Saffran,
M.Xu,
A.Drew,
P.Merkel,
S.Szilvassy,
R.L.Brake.
|
|
|
Ref.
|
|
J Med Chem, 2012,
55,
6523-6540.
|
|
|
PubMed id
|
|
|
|
|
|
Abstract
|
|
|
No abstract given.
|
|
|
|
|
|
|
